膀胱癌：尿液中的表皮生长因子受体（EGFR）和上皮细胞黏附分子（EpCAM）可预测癌症特异性生存率。 - Suppr

Bladder cancer: Urinary EGFR and EpCAM predict cancer-specific survival.

作者信息

Sidaway Peter

出版信息

Nat Rev Urol. 2015 Apr;12(4):184. doi: 10.1038/nrurol.2015.55. Epub 2015 Mar 17.

DOI:10.1038/nrurol.2015.55

PMID:25782173

Abstract

摘要

相似文献

Bladder cancer: Urinary EGFR and EpCAM predict cancer-specific survival.

Nat Rev Urol. 2015 Apr;12(4):184. doi: 10.1038/nrurol.2015.55. Epub 2015 Mar 17.

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.

Br J Cancer. 2015 Mar 17;112(6):1052-8. doi: 10.1038/bjc.2015.21.

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential.

Br J Cancer. 2014 Feb 4;110(3):679-85. doi: 10.1038/bjc.2013.744. Epub 2013 Nov 28.

Re: Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.

J Urol. 1998 Sep;160(3 Pt 1):838. doi: 10.1016/S0022-5347(01)62807-6.

Re: The BTA stat test is nonspecific for hematuria: an experimental hematuria model.

J Urol. 2002 Dec;168(6):2556; author reply 2556-7. doi: 10.1016/S0022-5347(05)64208-5.

[Role of urinary cytology in the study of bladder cancer. Comparison with the BTA test].

Arch Ital Urol Androl. 1999 Dec;71(5):279-82.

Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.

Int J Med Sci. 2017 Jul 19;14(9):811-819. doi: 10.7150/ijms.19929. eCollection 2017.

Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.

Tumour Biol. 2016 Oct;37(10):14329-14330. doi: 10.1007/s13277-016-5223-7. Epub 2016 Jul 22.

Biochemical and immunologic diagnosis of cancer. Urinary immunocytology and bladder carcinomas.

Tumour Biol. 1987;8(2-3):105.

[Improvement of the determination of urinary tissue polypeptide antigen (TPA) and the clinical study in bladder cancer patients].

Nihon Hinyokika Gakkai Zasshi. 1988 Dec;79(12):1954-61. doi: 10.5980/jpnjurol1928.79.12_1954.

引用本文的文献

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk.

Sci Rep. 2016 Jun 23;6:28611. doi: 10.1038/srep28611.

本文引用的文献

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.

Br J Cancer. 2015 Mar 17;112(6):1052-8. doi: 10.1038/bjc.2015.21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bladder cancer: Urinary EGFR and EpCAM predict cancer-specific survival.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献